The National Advertising Division (NAD) of the Council of Better Business Bureaus (BBB) is referring advertising for the dietary supplement Colotox, from Phoenix-based Central Coast Nutraceuticals Inc., to the FDA and FTC for review. Under its National Advertising Review Council (NARC) program, NAD had asked the company for substantiation of certain claims for its product, but received no response from Central Coast.
Claims for Colotox addressed the product’s ability to “remove toxic buildup,” “detoxify your organs” and “lose excess weight” as well as helping to relieve “ailments” including low energy, bloating and excess weight. NAD sought additional substantiation for implied claims related to colon cancer prevention. Read the entire press release